Leadership Specialists

Leadership expertise for private equity, portfolio companies & management teams

Pre & Post Deal

We offer our clients the smartest insights on their potential & current leadership teams to help drive maximum returns. Our insights are derived from Drax’s role as the leading executive recruiter for private equity invested companies, heavily supported by our proprietary data platform drxDigital.

We support our clients with access, insights & opportunities to deal advisors, leadership development, & management teams. In a results driven environment our passion is leadership.


Leadership teams within private equity backed company environments often don’t require any more motivation to succeed. Our support is grounded in practical actions that individuals & teams can own.

Our capabilities are a blend from the best of psychology with actual leadership experience within a PE backed company. Authenticity is core to the situations in which we support.



We believe upper quartile exits occur when leadership is equal to the opportunity. But these are dynamic factors both capable of significant challenge & chance.

An exit is a hard data point measuring the effectiveness of the leadership team; it also presents a unique occasion to work towards a shared tangible future objective.




LEADERSHIP: Optimising Human Capital

"The single biggest way to impact an organization is to focus on leadership development. There is almost no limit to the potential of an organization that recruits good people, raises them up as leaders and continually develops them." - John Maxwell Upgrade a...

Read more


The Carlyle Group invests in Memsource

The Carlyle Group has acquired a majority stake in Memsource, a language translation software provider. Founded in 2010 and headquartered in Prague, Czech Republic, Memsource is a translation technology provider that assists global corporations and the language...

Read more

Inflexion acquires Rosemont Pharmaceuticals

Inflexion will acquire Rosemont Pharmaceuticals, a UK liquid pharmaceuticals business. Rosemont has a portfolio of over 130 oral liquid medicines, including over 70 licensed products which are sold into the UK, US, Europe and the Middle East. Howard Taylor, CEO of...

Read more

Keep up to date with our monthly newsletter. Sign up below.


What do our clients say about us?

Andrew Steel

Andrew Steel

Managing Partner, Cairngorm Capital

"We have used Drax pretty extensively across our range of portfolio companies; I would use them again and recommend them."

Andrew Steel
Chris Sellers

Chris Sellers

Portfolio Chair and NED

"What has always set them apart is the effort and intellect they put into understanding what I am trying to achieve."

Chris Sellers
Bob Darling

Bob Darling

CEO, Jensten

"I felt well informed and feedback from applicants was that they had been treated with huge respect."

Bob Darling


Click below to view a case study